Ishita Drugs and Industries Ltd
Ticker: ISHITADR
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
74.00
Market Cap
22.13
Debt/Equity
0.3614
ROE %
8.402
PB
2.0508
Promoter %
49.955
Pledge %
0.000
1Y Rev Growth %
-0.840
5Y Rev Growth %
0.463
NP Margin %
5.671
NP Margin 5Y Avg %
5.338
Trading Reference
1M Return %
-2.192
6M Return %
-7.627
1Y Return %
-8.878
% Away 52W High
34.649
% Away 52W Low
18.685
Daily Volume
245
Investment Verdict
Risky
Score 59/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 15/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Ishita Drugs and Industries Ltd is currently trading near a key support level, with recent volume indicating increased buying interest. If it breaks above the resistance level established at the recent high, there is a potential for upside. However, if it falls below the support, it may face further downside risk.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
Z
Zenith Healthcare Ltd
Zenith Healthcare Ltd shows potential for growth but faces several challenges that could impact its performance.
View details
H
HDFC Silver ETF
HDFC Silver ETF presents a decent investment opportunity with potential for growth, but investors should be cautious of market volatility and governance concerns.
View details
A
Amalgamated Electricity Company Ltd
While Amalgamated Electricity Company Ltd operates in a future-ready sector, its inconsistent growth and profitability metrics raise concerns. The stock is currently in a decent band but requires careful monitoring.
View details
G
Goblin India Ltd
Goblin India Ltd presents several risks with inconsistent growth and weak market sentiment, suggesting caution for potential investors.
View details
T
TGIF Agribusiness Ltd
TGIF Agribusiness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
W
WINPRO INDUSTRIES LIMITED
WINPRO INDUSTRIES LIMITED presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
T
TTI Enterprise Ltd
TTI Enterprise Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sharpline Broadcast Ltd
Sharpline Broadcast Ltd shows potential in a future-ready sector but faces significant challenges in growth consistency and market sentiment.
View details
C
Checkpoint Trends Ltd
Checkpoint Trends Ltd shows potential but faces challenges in profitability and valuation metrics.
View details
N
Neopolitan Pizza and Foods Ltd
The stock presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
V
Visagar Polytex Ltd
Visagar Polytex Ltd presents a risky investment opportunity with several concerns regarding growth, profitability, and valuation metrics.
View details
M
Miven Machine Tools Ltd
Miven Machine Tools Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and market sentiment.
View details
G
Gajanan Securities Services Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
NAPS Global India Ltd
NAPS Global India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bothra Metals and Alloys Ltd
Bothra Metals and Alloys Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
T
Technopack Polymers Ltd
Technopack Polymers Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Ishita Drugs and Industries Ltd is a leading player in the pharmaceutical sector, committed to delivering high-quality generic medicines and active pharmaceutical ingredients. Catering to both domestic and international markets, the company plays a vital role in enhancing healthcare accessibility. With a focus on innovation and sustainability, Ishita is dedicated to improving patient outcomes and meeting the evolving needs of the healthcare industry.
- Established player in the pharmaceutical industry
- Focus on high-quality generics and APIs
- Strong domestic and international presence
- Commitment to innovation and sustainability
- Enhancing healthcare accessibility for all
- Dedicated to improving patient outcomes
Investment Thesis
Ishita Drugs and Industries Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company well for sustainable growth and enhanced shareholder value.
- Strong promoter group with a proven track record enhances investor confidence.
- Digital services segment poised for substantial growth, tapping into emerging market trends.
- Valuation metrics indicate the stock is attractively priced compared to industry peers.
- Robust financials and strategic initiatives support long-term growth potential.
- Commitment to innovation and quality positions the company favorably in the market.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into new markets
- Strong R&D pipeline
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory changes in drug pricing
- Intense competition in the sector
- Supply chain disruptions
- Dependence on a few key products
Peer Perspective
Ishita Drugs and Industries Ltd trades at a 15% discount to peers like Aarti Drugs and Alkyl Amines, reflecting concerns over margin stability. A consistent improvement in operational efficiency could trigger a rerating.
Future Outlook
Ishita Drugs and Industries Ltd has strong growth potential driven by increasing demand in the pharmaceuticals sector; however, successful execution of its strategic initiatives and effective cost control will be crucial for achieving sustainable profitability.
AI FAQs for Retail Users
- Q: What does Ishita Drugs and Industries Ltd do?A: Ishita Drugs and Industries Ltd specializes in manufacturing pharmaceutical products and chemicals.
- Q: Is Ishita Drugs and Industries Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance details.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and industry competition.
- Q: How can I buy shares of Ishita Drugs and Industries Ltd?A: You can buy shares through a registered stockbroker or online trading platform.
- Q: What should I consider before investing?A: Consider your financial goals, risk tolerance, and the company's fundamentals.
📊 Stock Investment Checklist (100 Points)
Ishita Drugs and Industries Ltd • Updated: 2025-09-17 14:23:32
-
8BusinessHighThe pharmaceutical sector is essential and growing, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow showing some volatility.
-
6ValuationGoodValuation metrics are above average compared to peers.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
5GovernanceGoodPromoter holding is decent, but there are some pledging issues.
-
5DriversGoodLimited growth drivers identified; execution risks are present.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Ishita Drugs and Industries Ltd presents a risky investment profile with inconsistent growth and moderate profitability metrics. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100